Paediatric Emergency Department, Autonomous University of Barcelona, University Hospital Vall d'Hebron, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.
Eur J Pediatr. 2011 Mar;170(3):371-8. doi: 10.1007/s00431-011-1399-4. Epub 2011 Jan 28.
In June 2009, the first influenza pandemic of the twenty-first century, due to the swine origin influenza A (H1N1) 2009 virus, was declared. This study aimed to describe the epidemiological and clinical features, complications, lethality and risk factors for hospital admission of microbiologically confirmed cases of influenza A (H1N1) 2009 infection seen at the emergency department of a children's hospital. All cases of children with influenza A (H1N1) 2009 viral infection, confirmed microbiologically by real-time reverse transcription polymerase chain reactions and treated in the emergency room between July and December 2009, were prospectively included. Patients were compared according to admission requirement to study variables associated with the risk of hospitalisation. Oseltamivir was the antiviral used for the treatment and its safety was analysed. Four hundred and twelve patients with influenza A (H1N1) 2009 infection were included. The most frequent symptoms were: fever (96%), cough (95%) and coryza (90%). Eighty-five patients (20.6%) were admitted: three to the paediatric intensive care unit and two died. Hospitalised children were younger than those not admitted (median age 5 vs 8 years; p = 0.001). Age under 1 year (OR 6.01; CI 95% 2.77-13.05), pneumonia (OR 7.99; CI 95% 3.50-18.22) and haemoglobinopathy or underlying blood disorders (OR 5.99; CI 95% 1.32-27.30) were statistically significant risk factors for admission. No differences were observed regarding onset of antiviral treatment among admitted and non-admitted patients. Treatment with oseltamivir was well tolerated. In conclusion, the incidence of severe cases and lethality of influenza A (H1N1) 2009 infection were low in our setting, even in a population with risk factors for developing complications.
2009 年 6 月,由于源自猪的甲型 H1N1 流感病毒,宣布了 21 世纪的第一次流感大流行。本研究旨在描述在儿童医院急诊科发现的经微生物学证实的甲型 H1N1 2009 流感感染的流行病学和临床特征、并发症、死亡率以及住院的危险因素。2009 年 7 月至 12 月期间,通过实时逆转录聚合酶链反应微生物学确诊并在急诊科接受治疗的所有甲型 H1N1 2009 病毒感染患儿均前瞻性纳入研究。根据入院要求比较患者,以研究与住院风险相关的变量。奥司他韦是用于治疗的抗病毒药物,并对其安全性进行了分析。共纳入 412 例甲型 H1N1 2009 感染患者。最常见的症状是:发热(96%)、咳嗽(95%)和流涕(90%)。85 例(20.6%)患者入院:3 例入住儿科重症监护病房,2 例死亡。住院患儿较未入院患儿年龄小(中位数年龄 5 岁 vs 8 岁;p = 0.001)。年龄小于 1 岁(OR 6.01;95%CI 2.77-13.05)、肺炎(OR 7.99;95%CI 3.50-18.22)和血红蛋白病或潜在血液疾病(OR 5.99;95%CI 1.32-27.30)是入院的统计学显著危险因素。入院患者和未入院患者的抗病毒治疗开始时间无差异。奥司他韦治疗耐受性良好。结论,即使在有发生并发症风险的人群中,我们的环境中甲型 H1N1 2009 感染的严重病例发生率和死亡率也较低。